Pellerin, David
Heindl, Felix
Traschütz, Andreas
Rujescu, Dan
Hartmann, Annette M.
Brais, Bernard
Houlden, Henry
Dufke, Claudia
Riess, Olaf
Haack, Tobias
Strupp, Michael
Synofzik, Matthis http://orcid.org/0000-0002-2280-7273
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung
Horizon 2020 (779257)
Bundesministerium für Bildung und Forschung (01EO 1401)
Deutsche Forschungsgemeinschaft (441409627)
EJP RD COFUND-EJP (825575)
Fondation Groupe Monaco
Fondation de l'Hôpital Général de Montréal (PT79418)
Wellcome Trust
Medical Research Council
Universitätsklinikum Tübingen
Article History
Received: 30 December 2023
Revised: 26 January 2024
Accepted: 27 January 2024
First Online: 21 February 2024
Declarations
:
: DP reports no disclosures. FH reports no disclosures. AT reports no disclosures. DR has received grant/research support from Janssen and Lundbeck; he has served as a consultant or on advisory boards for AC Immune, Janssen, Roche and Rovi and he has served on speakers´ bureaus of Janssen and Pharmgenetix. He also received honoraria from Gerot Lannacher, Janssen and Pharmgenetix, and travel support from Angelini and Janssen, all unrelated to the present manuscript. AMH reports no disclosures. BB reports no disclosures. HH reports no disclosures. CD reports no disclosures.OR reports no disclosures. TH reports no disclosures. MSt is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speakers honoraria from Abbott, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, J&J, MSD, NeuroUpdate, Otometrics, Pierre-Fabre, TEVA, UCB, and Viatris. He receives support for clinical studies from Decibel, U.S.A., Cure within Reach, U.S.A. and Heel, Germany. He distributes M-glasses and Positional vertigo App. He acts as a consultant for Abbott, AurisMedical, Bulbitec, Heel, IntraBio, Sensorion and Vertify. He is an investor and share-holder of IntraBio. All are unrelated to the present manuscript. MSy has received consultancy honoraria from Janssen, Ionis, Orphazyme, Servier, Reata, Biohaven, Zevra, Lilly, GenOrph, and AviadoBio, all unrelated to the present manuscript.
: This study was approved by the ethics committee of the LMU Munich and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent from all the participants was obtained.